Steven M. Greenberg

Steven M. Greenberg
Director, Hemorrhagic Stroke Research Program, Massachusetts General Hospital, John J. Conway Chair of Neurology, Harvard Medical School
Massachusetts General Hospital, Harvard Medical School
(617) 726-1728
Intracerebral hemorrhage, cerebral amyloid angiopathy
Lab Website: Greenberg Lab

Steven M. Greenberg MD, PhD, is the director of the Hemorrhagic Stroke Research Program at the Massachusetts General Hospital and John J. Conway Chair of Neurology at the Harvard Medical School. Initiated in 1994, the Hemorrhagic Stroke Research Program has become internationally recognized as a leading authority on the causes, diagnosis, and treatment of cerebral amyloid angiopathy. Dr. Greenberg has authored over 82 research articles and over 35 chapters, reviews, and editorials, served as Principal Investigator on multiple national research grants and in leadership positions at national and international conferences on hemorrhagic stroke and vascular cognitive impairment.
Dr. Greenberg received his undergraduate degree in biochemistry from Harvard University and his MD/PhD degrees from Columbia University under the graduate research training of Dr. James H. Schwartz.  He served his internship at the Pennsylvania Hospital, did his neurology residency at the Massachusetts General Hospital, and finished his post-doctoral fellowship at the Brigham and Women’s Hospital’s Center for Neurologic Diseases.

Eckman MH, Rosand J, Greenberg SM, Gage BF. Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients with Nonvalvular Atrial Fibrillation. Ann Intern Med 2009: 150:  73-83.
Garcia-Alloza M, Prada C, Latltarulo C, Fine S, Borrelli LA, Betensky R, Greenberg SM, Frosch MP, Bacskai BJ.  Matrix Metalloproteinase Inhibtion Reduces Oxidative Stress Associated with Cerebral Amyloid Angiopathy In Vivo In Transgenic Mice.  J Neurochem 2009; 109:  1636-1647.
Goldstein JN, Fazen LE, Wendell L, Chang Y, Rost NS, Snider R, Schwab K, Chanderraj R, Kabrhel C, Kinnecom C, Fitzmaurice E, Smith EE, Greenberg SM, Rosand J. Risk of Thromboembolism Following Acute Intracerebral Hemorrhage. Neurocrit Care; 2009; 10:  28-34.
Greenberg SM, Nandigam RNK, Delgado P, Betensky RA, Rosand J, Viswanathan A, Frosch MP, Smith EE. Microbleeds Versus Macrobleeds:  Evidence for Distinct Entities. Stroke 2009: 40:  2382-2386. [PMCID:  2758289].
Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Salman RA, Warach S, Launer LJ, Van Buchem MA, Breteler MM, Microbleed Study Group.  Cerebral Microbleeds:  A Guide to Detection and Interpretation.  Lancet Neurol 2009;  8:  165-174.
Kimberly WT, Gilson A, Rost NS, Rosand J, Viswanathan A, Smith EE, Greenberg SM. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 2009; 72:  1230-1235. [PMCID:  2677484].
Kumar MA, Rost NS, Snider RW, Chanderraj R, Greenberg SM, Smith EE, Rosand J. Anemia and Hematoma Volume in Acute Intracerebral Hemorrhage. Crit Care Med 2009;  37:  1442-1447.
Nandigam RNK, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, Greenberg SM, Dickerson BC. MRI Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Slice Thickness, and Field Strength. Am J Neuroradiol 2009; 30:  338-343. [PMCID:  2760298].
Oleinik A, Romero JM, Schwab K, Lev MH, Jhawar N, Almandoz JE, Smith EE, Greenberg SM.  CT Angiopathy for Intracerebral Hemorrhage does not Increase Risk of Acute Nephropathy.  Stroke 2009; 40:  2393-2397.
Patel PV, Fitzmaurice E, Nandigam RN, Auluck P, Viswanathan A, Goldstein JN, Rosand J, Greenberg SM, Smith EE. Association of Subdural Hematoma with Increased Mortality in Lobar Intracerebral Hemorrhage.  Arch Neurol 2009; 66:  79-84. [PMCID:  3085991].
Smith EE, Greenberg SM. Beta-Amyloid, Blood Vessels, and Brain Function. Stroke 2009; 40:  2601-2606. [PMCID:  2704252].
van Rooden S, van der Grond J, van den Boom R, Haan J, Linn J, Greenberg SM, van Buchem MA. Descriptive Analysis of the Boston Criteria Applied to a Dutch-Type Cerebral Amyloid Angiopathy Population. Stroke 2009; 40:  3022-3027.
Verbeek MM, Kremer BP, Olde Rikkert M, van Domburg PH, Skehan ME, Greenberg SM. Cerebrospinal Fluid Amyloid fl40 is Decreased in Cerebral Amyloid Angiopathy. Ann Neurol 2009: 66:  245-249.
Viswanathan A, Raj S, Greenberg SM, Stampfer M, Campbell S, Hyman BT, Irizarry MC. Plasma Abeta, Homocysteine, and Cognition:  the Vitamin Intervention for Stroke Prevention (VISP) Trial.  Neurology 2009;  72:  268-272. [PMCID:  2677526].
More publications may be found at

Resize text-+=